Infographic: Digital Measures in Oncology Drug Development

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration. This infographic provides a snapshot of the current state of cancer drug research, the use of motion-tracking wearables within oncology clinical trials, and the benefits and opportunities that digital endpoint data offers within this challenging therapeutic area.




Watch the On-Demand Webinar

ActiGraph CEO, Jeremy Wyatt joins a panel of thought leaders from VivoSense, Covance, Keck School of Medicine of USC, and Moffitt Cancer Center to discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer. They also discuss the reasons behind, and the missed opportunities from, the slow adoption of such tools.

On-Demand Webinar: Oncology Research and Care: Reimagining Digital Innovation

Interested in receiving more articles like this?

Subscribe to Our Blog



Back to Blog

Recent Articles

Why Prioritizing Patients Changes How Study Teams Approach DHTs

Although technology provides vast opportunities to improve clinical trial efficiency and unlock new...

The Vital Role of Clinical Research Sites in DHT Deployment

Once your team has made the decision to collect digital measures in your clinical trial and...

Bridging the Knowledge Gap on Digital Clinical Measures: A Technology Partner’s Perspective on ‘The Playbook’

ActiGraph was one of the very first commercial providers of wearable motion-sensing technology,...